Clin2
NCT06736184Likely a fitNot yet recruiting

Protecting hearts by managing potassium levels in dialysis patients

Chronic Kidney Disease on HemodialysisHypokalemiaHyperkalemiaMyocardial Injury

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests whether managing potassium levels better can protect the heart in people on long-term dialysis. It aims to show how reducing ups and downs in potassium might lower heart risks.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have been on maintenance hemodialysis for at least 3 months.
  • Your predialysis potassium level is between 5.0 and 8.0 mmol/L.
  • You are able to make your own medical decisions and have complete medical records.
  • You do not have certain serious heart conditions, active infections, or cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05090865Recruiting
Increase dietary potassium before dialysis

This study tests whether eating a higher-potassium diet is safe and helpful for people with early-to-moderate kidney failure who are not yet on dialysis. You may be asked to follow a specific diet plan and have blood tests to monitor potassium and other health markers.

Winnipeg, Manitoba
NCT06635590Recruiting
Kidney disease, high potassium, and heart changes

This study looks at how high potassium levels (hyperkalemia) in people with chronic kidney disease may affect the heart. Doctors will use echocardiograms (heart ultrasounds) to check for changes.

Ankara
NCT06940414Recruiting
Study of high potassium in kidney disease patients in community

This study looks at how common high potassium levels are in people with chronic kidney disease who are not on dialysis. It may help find who is at risk and how to prevent it.

Shanghai, Shanghai Municipality
NCT06256991Recruiting· Phase 4
Potassium management for kidney health

This study tests if careful potassium management can help people with chronic kidney disease (CKD) safely take higher doses of blood pressure medicines called ACE inhibitors or ARBs, which are known to protect the kidneys. You may be eligible if you have moderate to advanced CKD and are already on a moderate dose of one of these medications.

Groningen
NCT07772856Not yet recruiting
Relaxing potassium limits for people on hemodialysis

This study looks at whether people on hemodialysis can safely eat more potassium-rich foods instead of following the usual low-potassium diet. It aims to improve quality of life and possibly adjust dietary restrictions.

Toronto, Ontario
NCT07251309Recruiting· Phase 3
Study of WS016 for treating high potassium levels

This trial tests a new drug called WS016 to lower high potassium levels in adults. High potassium can be dangerous for your heart, and this study aims to find out if WS016 is safe and effective.

Bengbu, Anhui

Hear when a new Chronic Kidney Disease on Hemodialysis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.